Paid Clinical Trials Louisville

Discover 600 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 600

ProTractX3™ DCBPaclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Recruiting

PHASE3

Sponsor:

GIE Medical

Location:

Louisville KY, Nashville TN, St Louis MO, Chicago ILshow 22 more

Code:

NCT05561127

Conditions

Bowel; Stricture

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

GIE Medical ProTractX3 TTS DCB

Control

HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Louisville KY, Nashville TN, Cleveland OH, Detroit MIshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Observational StudyPulmonary Hypertension Association Registry

Recruiting

Sponsor:

Pulmonary Hypertension Association, Inc.

Location:

Louisville KY, Cincinnati OH, Indianapolis IN, Nashville TNshow 39 more

Code:

NCT04071327

Conditions

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Hypertension

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

FrexalimabEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Louisville KY, Lexington KY, Cincinnati OH, Centerville OHshow 80 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

Immunotherapy & Irreversible ElectroporationImmunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Recruiting

PHASE2

Sponsor:

University of Louisville

Location:

Louisville KY

Code:

NCT03080974

Conditions

Pancreatic Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Irreversible Electroporation

SBRT & PembrolizumabSBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Recruiting

PHASE2

Sponsor:

RTOG Foundation, Inc.

Location:

Louisville KY, Cincinnati OH, Columbus OH, Saint Louis MOshow 15 more

Code:

NCT03546582

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Stereotactic Body Radiation Therapy (SBRT)

Nivolumab, Ipilimumab, CabozantinibTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Louisville KY, Shepherdsville KY, Bardstown KY, Lexington KYshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

AvacopanA Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting

Sponsor:

Amgen

Location:

New Albany IN, Lexington KY, Miamisburg OH, Nashville TNshow 33 more

Code:

NCT06072482

Conditions

Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Avacopan

Placebo

Standard of Care

Efgartigimod AlfaA Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Recruiting

Sponsor:

argenx

Location:

Louisville KY, O'Fallon IL, St. Petersburg FL, Austin TXshow 1 more

Code:

NCT06298565

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

efgartigimod

LP-184Study of LP-184 in Patients with Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Lantern Pharma Inc.

Location:

Louisville KY, Indianapolis IN, Rolling Meadows IL, Springdale ARshow 5 more

Code:

NCT05933265

Conditions

Advanced Solid Tumor

Metastatic Solid Tumor

GBM

TNBC - Triple-Negative Breast Cancer

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LP-184

Spironolactone

Olaparib